High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC.

Saved in:
Bibliographic Details
Title: High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC.
Authors: Førde D; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Kilvær T; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Pedersen MI; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Urbarova I; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Paulsen EE; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Pulmonology, University Hospital of North Norway, Tromsø, Norway., Rakaee M; Department of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Busund LR; Department of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Donnem T; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Andersen S; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
Source: Frontiers in immunology [Front Immunol] 2024 Dec 19; Vol. 15, pp. 1504220. Date of Electronic Publication: 2024 Dec 19 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1504220